Please enable Javascript
Conferences
Expert Interviews
Roundtable
Mesothelioma
Non-Small Cell Lung Cancer
ALK+ NSCLC
EGFR+ NSCLC
EGFR+ NSCLC Learning Lab
Immunotherapy in NSCLC
KRAS+ NSCLC
Small Cell Lung Cancer
John Wrangle, MD, MPH
Articles by John Wrangle, MD, MPH
Dr. Wrangle Discusses Phase 2b QUILT 3.055 Trial at IASLC 2024 World Conference on Lung Cancer
John Wrangle, MD, MPH
WCLC 2024
|
February 28, 2025
The trial is investigating nogapendekin alfa inbakicept-pmln in combination with immune checkpoint inhibitor therapy.
View More